We spoke with Gary Nabel about research funding, making the move from academia to industry, transformative innovation to improve global health, and the current state of the infectious disease drug pipeline.
This is a preview of subscription content, access via your institution
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 digital issues and online access to articles
$119.00 per year
only $9.92 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Rights and permissions
About this article
Cite this article
Pariente, N. Making medicines that save lives. Nat Microbiol 2, 17060 (2017). https://doi.org/10.1038/nmicrobiol.2017.60
Published:
DOI: https://doi.org/10.1038/nmicrobiol.2017.60